AnalystsMadhu Kumar
Madhu Kumar's Stock Forecasts

Analyst Ranking
Top 3%
#77 out of 3582 analysts
Average Return
+33.79%
Win Rate
56%31 out of 55
Risk vs Reward
Poor
Good

Madhu Kumar's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Catalyst Biosciences IncCBIO
+450.00%$4.38$24.09
2017-06-11 -
2018-06-12
Strong Buy
Scholar Rock Holding CorpSRRK
+331.26%$14.97$64.56
2020-03-11 -
2021-03-12
Buy
Arbutus Biopharma CorpABUS
+309.92%$1.21$4.96
2020-03-26 -
2020-07-24
Buy
Clementia Pharmaceuticals IncCMTA
+211.47%$8.46$26.35
2018-08-14 -
2019-04-17
Strong Buy
Arcturus Therapeutics Holdings IncARCT
+206.96%$13.80$42.36
2020-02-10 -
2020-12-29
Buy

Madhu Kumar's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Passage BIO IncPASG
1Hold$6.00+21.21%Downgrades
6 days ago
Arrowhead Pharmaceuticals IncARWR
5Strong BuyN/AN/AUpgrades
6 days ago
Design Therapeutics IncDSGN
1Strong Sell$10.00-14.97%Initiates Coverage On
6 days ago
Arvinas IncARVN
1Strong Buy$157.00+129.26%Initiates Coverage On
6 days ago
Magenta Therapeutics IncMGTA
1Strong Buy$8.00+128.57%Upgrades
19 days ago
Horizon Therapeutics Public Ltd CoHZNP
1Strong Buy$168.00+93.44%Upgrades
2 months ago
Applied Therapeutics IncAPLT
1Strong Sell$10.00+200.30%Downgrades
5 months ago
Dicerna Pharmaceuticals IncDRNA
5Hold$25.00-34.59%Downgrades
5 months ago
Arcturus Therapeutics Holdings IncARCT
3Strong Sell$29.00+16.47%Downgrades
5 months ago
Dynavax Technologies CorpDVAX
1Strong Buy$19.00+50.79%Initiates Coverage On
6 months ago
Krystal Biotech IncKRYS
1Strong Buy$90.00+57.73%Upgrades
6 months ago
Intellia Therapeutics IncNTLA
5Hold$85.00-3.64%Maintains
7 months ago
Iovance Biotherapeutics IncIOVA
2Strong Buy$97.00+558.52%Initiates Coverage On
9 months ago
Apellis Pharmaceuticals IncAPLS
5Strong Buy$130.00+235.22%Initiates Coverage On
9 months ago
Editas Medicine IncEDIT
3Strong Sell$20.00+8.23%Initiates Coverage On
9 months ago
Cellectis SACLLS
2Buy$39.00+491.81%Upgrades
10 months ago
Gritstone bio IncGRTS
1Sell$8.00N/ADowngrades
a year ago
Cellular Biomedicine Group IncCBMG
2Hold$19.00N/ADowngrades
a year ago
uniQure NVQURE
2Buy$57.00N/AUpgrades
a year ago
Arbutus Biopharma CorpABUS
8HoldN/AN/ADowngrades
2 years ago
Aprea Therapeutics IncAPRE
1Buy$45.00N/AInitiates Coverage On
2 years ago
Vir Biotechnology IncVIR
1Sell$20.00N/AMaintains
2 years ago
Pieris Pharmaceuticals IncPIRS
1Buy$5.00N/AUpgrades
2 years ago
Scholar Rock Holding CorpSRRK
1Buy$35.00N/AInitiates Coverage On
2 years ago
Leap Therapeutics IncLPTX
1Buy$6.00N/AInitiates Coverage On
2 years ago
Spark Therapeutics IncONCE
1Strong Buy$71.00N/AUpgrades
3 years ago
EyePoint Pharmaceuticals IncEYPT
1Strong Buy$6.00N/AMaintains
3 years ago
Assembly Biosciences IncASMB
3Strong Buy$42.00N/AUpgrades
3 years ago
Tetraphase Pharmaceuticals IncTTPH
1Strong Buy$7.00N/AMaintains
3 years ago
Immunomedics IncIMMU
1Strong Buy$55.00N/AMaintains
3 years ago
Clementia Pharmaceuticals IncCMTA
2Strong Buy$16.00N/AMaintains
3 years ago
Alnylam Pharmaceuticals IncALNY
2Strong Buy$230.00N/AMaintains
3 years ago
Regulus Therapeutics IncRGLS
3Hold$0.50N/AMaintains
4 years ago
Deciphera Pharmaceuticals IncDCPH
1HoldN/AN/ADowngrades
4 years ago
Catalyst Biosciences IncCBIO
2Strong Buy$75.00N/AMaintains
4 years ago
InflaRx NVIFRX
1Strong Buy$40.00N/AInitiates Coverage On
4 years ago
Akari Therapeutics PlcAKTX
3Hold$3.00N/AInitiates Coverage On
4 years ago
Achillion Pharmaceuticals IncACHN
1Hold$3.50N/AInitiates Coverage On
4 years ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$40.00N/AInitiates Coverage On
4 years ago
Tg Therapeutics IncTGTX
1Strong Buy$21.50N/AReinstates
4 years ago
CRISPR Therapeutics AGCRSP
1Strong Buy$23.50N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.